Evidence map›Paper›PMID 42163974›Full record

ArticleEClinicalMedicine2026

A Europe-wide provider perspective of healthcare services for adolescent and young adult patients with haematological conditions: a survey from the Adolescent and Young Adult Taskforce of the European Hematology Association.

Michiel H D Schoenaker, Charles Veal, Sally Batten, Nicolas Boissel, Yunus Borowczak, Raffaella Colombatti, Robin Doeswijk, Inken Hilgendorf, Charles McGrath, Kim Messelink and 4 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Michiel H D SchoenakerPrincess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Charles VealMembership Matters and Charles Veal Ltd, UK.
Sally BattenEuropean Hematology Association, the Netherlands.
Nicolas BoisselParis Cité University Saint-Louis Research Institute, Paris, France.
Yunus BorowczakCML Advocates Network, Bern, Switzerland.
Raffaella ColombattiUniversity of Padova, Padua, Italy.
Robin DoeswijkEuropean Hematology Association, the Netherlands.
Inken HilgendorfUniversitätsklinikum Jena, Klinik für Innere Medizin 2, Abteilung für Hämatologie und Internistische Onkologie, Jena, Germany.
Charles McGrathAcute Leukemia Advocates Network, Bern, Switzerland.
Kim MesselinkRadboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Maurizio MianoGiannina Gaslini Institute, Genoa, Italy.
Joanne YacobovichSchneider Children's Medical Center of Israel, Rina Zaizov Hematology Oncology Division, Petah Tikva, Israel.
Josef VormoorPrincess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Anna CastletonThe Christie Hospital NHS Trust, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adolescent and young adult (AYA) patients are a unique group at a crucial phase of physical, emotional, and social development. In terms of healthcare provision, the specific needs of AYAs are not optimally catered for by healthcare services designed to meet the needs of younger children or older adults. Although most of the advocacy for AYAs has been driven by medical oncology, within haematology the needs of AYA patients with both malignant and non-malignant, chronic diagnoses must be considered. Methods: The AYA Taskforce of the European Hematology Association (EHA) developed an online survey and distributed this to European healthcare providers, aiming to scope the existing pan-European landscape of AYA haematology service provision, identify barriers and facilitators to effective AYA care delivery, and inform the development of a strategic agenda for AYA within the organisation. Survey targeted the EHA membership, including a diverse range of clinical and academic professionals, as well as additional relevant organisations representing haematology nursing and allied health professionals. Findings: With 1490 respondents from diverse institutions across 43 European countries we obtained a pan-European overview of access to age-relevant care for AYA patients with haematological conditions. Survey responses articulate a non-uniform picture of whether, and how, AYA is defined for the purposes of structuring healthcare, and a varied provider perception of access to quality, age-relevant support for young people. Differences in age-appropriate provision for AYAs with malignant and non-malignant chronic haematological conditions, as well as the level of support offered to AYA patients for transition across the age-boundaries of existing healthcare infrastructure are highlighted. As particular challenges to providing optimal support for young people. Interpretation: This survey illustrates a heterogeneous recognition and provision of service need for AYA patients across Europe, with varied perception of quality of existing age-relevant services. Pan-European inequity in approaches for AYA patients with malignant versus chronic, non-malignant conditions poses a challenge that is relatively unique to the specialism of haematology and falls out of scope of previous advocacy initiatives for AYA patients primarily driven by the field of solid oncology. The paucity of available structured transition programs for AYAs with haematology conditions falls short of ensuring that this patient group are equipped with the necessary informational, psychological and social support infrastructure to promote effective engagement, ownership and management of individual healthcare need as patients move into older adulthood. An ambitious AYA strategy is required to address these and other key observations. Funding: None.

Indexed as

Adolescent and young adult (AYA)EuropeHaematologyMalignantNon-malignantService provisionSurvey

Identifiers

PMID42163974
PMCPMC13185923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.